Fundamentals of Bioavailability and BCS
111 Questions
0 Views

Fundamentals of Bioavailability and BCS

Created by
@DexterousFern6890

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What are the two parameters that govern drug absorption in the BCS classification?

  • Molecular weight and pH level
  • Solubility and permeability (correct)
  • Distribution and elimination
  • Chemical stability and formulation type
  • Why is dissolution testing significant in drug product development?

  • To measure the drug's potency
  • To assess the safety of the drug
  • To determine the drug's shelf life
  • To evaluate the release rate of a drug (correct)
  • What is the difference between absolute bioavailability and relative bioavailability?

  • Absolute bioavailability measures systemic exposure compared to an intravenous administration, while relative bioavailability is compared to a standard formulation. (correct)
  • Absolute bioavailability is specific to injectable drugs, and relative bioavailability is for oral doses only.
  • Absolute bioavailability refers to the total dose of a drug, and relative bioavailability refers only to oral doses.
  • Absolute bioavailability is the bioavailability in humans, and relative bioavailability is for animal studies.
  • Which factors affect drug absorption and bioavailability?

    <p>Physiological factors and drug formulation characteristics</p> Signup and view all the answers

    What is a characteristic feature of USP dissolution studies?

    <p>They determine the rate and extent of drug release from its dosage form.</p> Signup and view all the answers

    What is the percentage of bioavailability for drugs administered via the intravenous route?

    <p>100%</p> Signup and view all the answers

    What must occur for any drug administered via routes other than intravenous to enter the bloodstream?

    <p>Absorption process</p> Signup and view all the answers

    Which of the following best describes absolute bioavailability?

    <p>The percentage of the administered dose that reaches the systemic circulation intact</p> Signup and view all the answers

    If a drug administered orally has a bioavailability of 80%, what does this indicate?

    <p>Less than 100% of the drug reaches systemic circulation</p> Signup and view all the answers

    What does an increase in absorption imply regarding drug bioavailability?

    <p>Increased systemic circulation of the drug</p> Signup and view all the answers

    What is required by the U.S. FDA to control the quality of pharmaceutical products?

    <p>Dissolution testing data</p> Signup and view all the answers

    Which of the following parameters is NOT specified in the USP drug monographs for dissolution analysis?

    <p>Concentration of active ingredients</p> Signup and view all the answers

    What is the significance of measuring the time for 75% of the labeled amount of drug to dissolve according to USP guidelines?

    <p>To evaluate the drug's release profile</p> Signup and view all the answers

    What type of apparatus uses a rotating basket during the dissolution testing process?

    <p>Apparatus 1</p> Signup and view all the answers

    Which class of drugs typically has low solubility and low permeability?

    <p>Class IV</p> Signup and view all the answers

    What mechanism do most drugs use to permeate biological membranes?

    <p>Simple diffusion</p> Signup and view all the answers

    What condition must the dissolution medium be kept at during testing?

    <p>37 °C</p> Signup and view all the answers

    What role does a drug's ability to partition into a lipophilic membrane environment play?

    <p>It indicates whether the drug can cross the biomembrane</p> Signup and view all the answers

    What is a key characteristic of facilitated diffusion?

    <p>Is driven by the drug concentration gradient</p> Signup and view all the answers

    How does active transport differ from facilitated diffusion?

    <p>It can transport substances against their concentration gradient</p> Signup and view all the answers

    What is the role of the Caco-2 monolayer in studying drug permeation?

    <p>It simulates the physiological conditions of the small intestine</p> Signup and view all the answers

    Which statement is true regarding the factors affecting oral bioavailability?

    <p>pH variation can impact drug ionization and absorption</p> Signup and view all the answers

    What indicates successful formation of a Caco-2 monolayer?

    <p>High transepithelial electrical resistance (TEER)</p> Signup and view all the answers

    Which concept describes the competitive inhibition related to membrane transporters?

    <p>Substrate analogues can inhibit the transport process</p> Signup and view all the answers

    During active transport, which of the following is necessary?

    <p>Energy to drive the transport process</p> Signup and view all the answers

    What happens when the integrity of the Caco-2 monolayer is compromised?

    <p>Marker molecules permeate the monolayer</p> Signup and view all the answers

    What is the maximum number of hydrogen-bond donors according to Lipinski's Rule of Five for good oral absorption?

    <p>5</p> Signup and view all the answers

    Which of the following factors does not predict a compound's pharmacological activity according to Lipinski's Rule of Five?

    <p>Pharmacokinetics</p> Signup and view all the answers

    What role do excipients play in drug absorption?

    <p>They can modify the extent and rate of absorption.</p> Signup and view all the answers

    According to Lipinski's Rule of Five, what is the limit for hydrogen-bond acceptors?

    <p>10</p> Signup and view all the answers

    What is the maximum molecular weight suggested by Lipinski's Rule of Five to ensure good oral absorption?

    <p>500</p> Signup and view all the answers

    Which of the following does NOT represent a common type of drug based on the content?

    <p>Enzymes</p> Signup and view all the answers

    What is one key purpose of dissolution testing in drug product development?

    <p>To assess the rate and extent of drug absorption.</p> Signup and view all the answers

    Which of the following describes a scenario where excipients could modify drug absorption?

    <p>Selecting a specific disintegrant</p> Signup and view all the answers

    What is a key concern when using sustained release formulations in relation to alcohol intake?

    <p>Dose dumping due to barrier integrity breach</p> Signup and view all the answers

    What technology is employed in Meltrex Technology for controlled release formulations?

    <p>Hot melt extrusion</p> Signup and view all the answers

    What primary disadvantage is associated with matrix devices in drug release?

    <p>Continuous decrease in drug release rate</p> Signup and view all the answers

    Which statement about the Meltrex Technology is true?

    <p>It offers a solvent-free green formulation technology.</p> Signup and view all the answers

    In the context of drug release, what is essential to achieve zero order release from matrix devices?

    <p>Selecting a geometry that increases surface area</p> Signup and view all the answers

    What is a potential consequence of breaching the release control barrier in sustained release formulations?

    <p>Increased exposure to the active drug</p> Signup and view all the answers

    What is the main method of drug absorption that requires no energy?

    <p>Diffusion-controlled release</p> Signup and view all the answers

    Which of the following best describes the scalability of Meltrex Technology?

    <p>It allows for easily scalable processes.</p> Signup and view all the answers

    What is the main factor that determines the release rate of drug molecules in a diffusion-controlled release formulation?

    <p>The diffusion through the polymer material</p> Signup and view all the answers

    Which parameter is NOT necessary to maintain for a constant drug release rate from a reservoir device?

    <p>Temperature of the environment</p> Signup and view all the answers

    What role does the polymer material play in a reservoir diffusion system?

    <p>It acts as a barrier to control drug release</p> Signup and view all the answers

    Which of the following factors does NOT affect the release rate of a drug from a reservoir device?

    <p>Rate of drug absorption in the digestive tract</p> Signup and view all the answers

    What equation describes the release rate of a drug from a diffusion-controlled release formulation?

    <p>dM/dt = ADK ΔC / ℓ</p> Signup and view all the answers

    In a matrix diffusion system, what primarily influences drug release?

    <p>Interactions between drug and polymer matrix</p> Signup and view all the answers

    What is one reason why a combination of dissolution and diffusion may occur in microencapsulated material?

    <p>The encapsulation material may dissolve along with diffusion</p> Signup and view all the answers

    How is the partition coefficient significant in the context of diffusion-controlled release formulations?

    <p>It influences the rate of drug release across the membrane</p> Signup and view all the answers

    What is the primary function of cholestyramine in pharmaceuticals?

    <p>Reduce blood cholesterol levels</p> Signup and view all the answers

    Which statement accurately describes the action of osmotic controlled delivery systems?

    <p>They utilize osmotic pressure as the main drive for drug release.</p> Signup and view all the answers

    What determines the volume flow of water into the core of an osmotic system?

    <p>The osmotic pressure difference and membrane characteristics</p> Signup and view all the answers

    Which of the following is a cation exchange resin mentioned?

    <p>Sulfonated styrene</p> Signup and view all the answers

    What factor is crucial to ensuring that the hydrostatic pressure difference is minimized in an osmotic system?

    <p>The osmotic pressure difference must be substantially elevated.</p> Signup and view all the answers

    What is colestipol primarily used for?

    <p>Removing bile acids from the body</p> Signup and view all the answers

    Which property is associated with osmotic delivery systems?

    <p>They provide a customizable release profile for various APIs.</p> Signup and view all the answers

    What parameter is NOT included in the equation for volume flow of water into the core of an osmotic system?

    <p>Concentration of the drug, Cs</p> Signup and view all the answers

    What is the primary function of the push layer in the trilayer core of Concerta®?

    <p>To expand and release the drug through the orifice</p> Signup and view all the answers

    Which statement accurately describes the initial release of methylphenidate in Concerta®?

    <p>It involves the dissolution of an immediate-release overcoat within one hour.</p> Signup and view all the answers

    What is a benefit of gastroretentive drug delivery systems?

    <p>Enhanced therapeutic efficacy through prolonged contact time</p> Signup and view all the answers

    Which type of drug is most appropriate for use in gastroretentive drug delivery systems?

    <p>Drugs that are unstable in the intestinal environment</p> Signup and view all the answers

    What characteristic is essential for the orifice of Concerta® to function properly?

    <p>It needs to be precision-laser drilled to control drug release</p> Signup and view all the answers

    How does the average gastrointestinal transit time impact drug release from gastroretentive systems?

    <p>Longer transit times provide extended therapeutic effects.</p> Signup and view all the answers

    Why are certain drugs selected for gastroretentive delivery systems?

    <p>They have specific sites of action local to the stomach.</p> Signup and view all the answers

    What role does water play in the drug release mechanism of Concerta®?

    <p>It activates the push layer to begin drug release.</p> Signup and view all the answers

    Which type of gastroretentive system uses polymers that adhere to the stomach lining?

    <p>Bioadhesive systems</p> Signup and view all the answers

    Which mechanism is least effective in increasing gastric residence time for drugs?

    <p>Co-administration with agents that speed up gastric emptying</p> Signup and view all the answers

    What is a key characteristic of size increasing gastroretentive systems?

    <p>They should not affect gastric motility or emptying.</p> Signup and view all the answers

    Which of the following substances is NOT suitable for gastroretentive DDS?

    <p>Drugs stable in acidic pH</p> Signup and view all the answers

    How do effervescent floating systems maintain their position in the stomach?

    <p>Through the formation of gas bubbles</p> Signup and view all the answers

    Which of the following describes an appropriate action to avoid premature emptying of a gastroretentive dosage form?

    <p>Ensuring the dosage form expands in size</p> Signup and view all the answers

    What is one of the components used in an effervescent floating system?

    <p>Sodium bicarbonate</p> Signup and view all the answers

    Which characteristic of a gastric retentive system enhances its ability to be cleared from the stomach after multiple uses?

    <p>It should not adhere to the stomach lining.</p> Signup and view all the answers

    What is the primary advantage of using microencapsulation for drug delivery?

    <p>It forms a protective barrier to control drug release.</p> Signup and view all the answers

    In the Noyes-Whitney equation, what does 'D' represent?

    <p>Diffusion coefficient</p> Signup and view all the answers

    Which factor can be varied to control the rate of drug release in coated granules?

    <p>Thickness of the coating</p> Signup and view all the answers

    What is one key characteristic of microencapsulated particles?

    <p>They can be either solid, liquid, or gas.</p> Signup and view all the answers

    How does the composition of the coating material impact drug release?

    <p>It determines the interactions with physiological fluids.</p> Signup and view all the answers

    Which method utilizes oppositely charged aerosols for microencapsulation?

    <p>Electrostatic method</p> Signup and view all the answers

    What characteristic of a tablet matrix primarily controls the rate of drug dissolution?

    <p>Porosity of the tablet matrix</p> Signup and view all the answers

    Which coating material is suitable for interfacial polymerization in microencapsulation?

    <p>Water soluble and insoluble monomers</p> Signup and view all the answers

    Which method can be used to control drug release by manipulating the effective porosity of a tablet?

    <p>Matrix dissolution</p> Signup and view all the answers

    Which process is specifically associated with the use of low molecular weight lipids for coating?

    <p>Hot melt</p> Signup and view all the answers

    Which method of microencapsulation involves the dissolution of polymers in water or solvent?

    <p>Precipitation</p> Signup and view all the answers

    What primary factor influences the rate of penetration of dissolution fluid into a compressed tablet's matrix?

    <p>Surface area and porosity</p> Signup and view all the answers

    Which of the following processes does not use water soluble polymers for coating?

    <p>Hot melt</p> Signup and view all the answers

    What is a key advantage of osmotic controlled delivery systems?

    <p>Achievement of zero order release</p> Signup and view all the answers

    Which of the following parameters affects the release rate in osmotic systems?

    <p>Membrane thickness</p> Signup and view all the answers

    Which statement best describes the release mechanism of osmotic controlled delivery systems?

    <p>It is independent of the properties of the drug.</p> Signup and view all the answers

    What is a characteristic feature of the Single-composition osmotic tablet (SCOT)?

    <p>It includes a porous membrane for high drug loading.</p> Signup and view all the answers

    What factor influences the choice of membrane-forming polymers in osmotic systems?

    <p>Membrane permeability adjustments</p> Signup and view all the answers

    Which drug mentioned is an example of a self-emulsifying osmotic pump (SEOP)?

    <p>Carbamazepine</p> Signup and view all the answers

    In osmotic delivery systems, the release rate is not affected by which of the following?

    <p>Drug's mechanism of action</p> Signup and view all the answers

    What characteristic of osmotic delivery systems allows for delayed release functionality?

    <p>Controlled osmotic pressure</p> Signup and view all the answers

    Which type of drugs are unsuitable for gastroretentive drug delivery systems?

    <p>Drugs absorbed primarily in the small intestine</p> Signup and view all the answers

    What is a common method to increase the gastric residence time of dosage forms?

    <p>Administering with agents that slow gastric motility</p> Signup and view all the answers

    Which mechanism is employed in size increasing systems for gastroretentive drug delivery?

    <p>Expanding due to swellable excipients or shape modification</p> Signup and view all the answers

    What characteristic should a gastroretentive system have to avoid accumulation in the stomach after multiple doses?

    <p>A clearance mechanism from the stomach after a predetermined time</p> Signup and view all the answers

    Which of the following materials is used in effervescent floating systems for gastroretentive drug delivery?

    <p>Sodium bicarbonate and tartaric acid</p> Signup and view all the answers

    Which class of agents is commonly used in bioadhesive systems for gastroretentive formulations?

    <p>Bioadhesive polymers like sodium carboxymethyl cellulose</p> Signup and view all the answers

    What is the main role of high density systems in gastroretentive drug delivery?

    <p>To ensure prolonged gastric residence by settling at the bottom of the stomach</p> Signup and view all the answers

    What happens to the dosage form when it is immersed in the buffer at 37ºC in effervescent floating systems?

    <p>The solution permeates, leading to swelling and buoyancy</p> Signup and view all the answers

    Which of the following polymers is NOT used as an enteric polymer?

    <p>Eudragit L100</p> Signup and view all the answers

    What is a key characteristic of controlled release drug delivery systems?

    <p>They deliver the drug in a predetermined rate over time.</p> Signup and view all the answers

    Which term is synonymous with both 'controlled release' and 'prolonged release'?

    <p>Sustained release</p> Signup and view all the answers

    In a sustained release formulation, how is the initial dose typically administered?

    <p>As a loading dose followed by a maintenance dose.</p> Signup and view all the answers

    What distinguishes controlled release from sustained release dosages?

    <p>Controlled release is characterized by zero order release.</p> Signup and view all the answers

    Which of the following statements about enteric coated tablets is true?

    <p>They are insoluble at pH 6 or below but dissolve above pH 6.</p> Signup and view all the answers

    What kind of drug delivery does the term 'sustained release' imply?

    <p>It releases the drug slowly over a specified period.</p> Signup and view all the answers

    Why is controlled release considered advantageous?

    <p>It provides therapeutic levels of drug without concentration variation.</p> Signup and view all the answers

    Study Notes

    Bioavailability Fundamentals

    • Bioavailability is the proportion of a drug that reaches the bloodstream after administration.
    • Intravenous (IV) administration results in 100% bioavailability as the drug enters the bloodstream directly.
    • Other routes of administration involve absorption, where the drug must pass through barriers before reaching the bloodstream.

    BCS Classification of Drugs

    • Biopharmaceutical Classification System (BCS) categorizes drugs based on their solubility and permeability.
    • Class I Drugs: High solubility, high permeability, well-absorbed.
    • Class II Drugs: Low solubility, high permeability, absorption rate limited by dissolution.
    • Class III Drugs: High solubility, low permeability, absorption rate limited by membrane permeability.
    • Class IV Drugs: Low solubility, low permeability, absorption rate limited by both factors.

    In Vitro Dissolution Testing

    • Dissolution Testing is a critical component of drug product development to ensure quality.
    • USP (United States Pharmacopeia) provides detailed guidelines for conducting dissolution testing.
    • Dissolution testing parameters:
      • Dissolution medium type (pH, ionic strength)
      • Apparatus type (rotating basket or paddle)
      • Sampling time intervals
    • Dissolution Test Objectives:
      • Determine drug release kinetics
      • Ensure consistency between batches of drug products
      • Meet regulatory requirements.

    USP-Approved Dissolution Apparatus

    • Apparatus 1 (Rotating Basket): Rotates at specific rpm, suitable for harsh media.
    • Apparatus 2 (Paddle): Rotates at specific rpm, suitable for harsh media.

    Cell Culture Model for Permeation Studies

    • Caco-2 Monolayer: Utilizes differentiated human colon adenocarcinoma cells to model drug permeation across the intestinal mucosa.
    • Monolayer Characteristics:
      • Resembles small intestinal cells with microvilli, transporter systems, and tight junctions.
      • 15-21 days to form properly.
    • Integrity Check:
      • Non-permeation of a marker molecule or by measuring transepithelial electrical resistance (TEER).

    Oral Bioavailability Factors

    • Physiological Factors:
      • pH variations in the gastrointestinal tract affect drug ionization and dissolution.
      • Food consumption alters gastrointestinal motility and drug absorption.
    • Drug Factors:
      • Lipinski's Rule of Five: Predicts oral absorption based on drug properties.
      • Molecular Weight: High molecular weight drugs may have poor absorption.
      • LogP: High LogP values indicate high lipophilicity, potentially affecting membrane permeation.
    • Excipient Effects:
      • Excipients can modify drug absorption rates and extent.
      • Diluents can affect drug dissolution.
      • Lubricants can impact tablet disintegration.
      • Disintegrants enhance drug dissolution.

    Approaches for Improving Oral Bioavailability

    • Formulation Strategies:
      • Nanoparticle formulation
      • Microsphere formulation
      • Drug delivery systems
      • Salt formation
      • Prodrug development

    Comparative Release from IR and CR Formulations

    • Procainamide plasma concentrations are higher with slow-release tablets taken every 8 hours than with conventional tablets taken every 4 hours

    Meltrex Technology® for Controlled Release

    • A hot melt extrusion to tablet technology
    • Suitable for pharmaceutical formulations because it is a solvent-free green formulation technology
    • Well-established process in the polymer, food, and plastic industries
    • In-line PAT can be used to monitor product quality
    • Easily scalable

    Alcohol Induced Dose Dumping

    • Sustained-release formulations can be affected by the intake of alcohol, leading to "dose dumping".
    • Dose dumping is when the integrity of the barrier controlling the release rate is breached, resulting in increased exposure to the active drug, possible safety issues, and changes in clinical efficacy.

    Dissolution Controlled Formulations: Limitations

    • A major disadvantage of matrix devices is that drug release rate continuously decreases with time due to increased diffusional distance and decreased surface area at the penetrating solvent front.

    Diffusion Controlled Release Formulations

    • It is a major process for absorption in which no energy is required.
    • Drug molecules diffuse from a region of higher concentration to lower concentration until equilibrium is attained.
    • Release rate is directly proportional to the concentration gradient across the membrane.
    • Release rate is determined by its diffusion through a water-insoluble polymer.
    • Two types of diffusion devices:
      • Reservoir diffusion system
      • Matrix diffusion system

    Diffusion Controlled Release Formulations: Reservoir Devices

    • Drug is encased in a water-insoluble polymeric material.
    • Drug will partition into the membrane and exchange with the surrounding fluid.
    • The amount of drug released, the release rate dM/dt is given by the equation:
      dM/dt = ADK C/ ℓ
      
      where: - A is the area - D is the diffusion coefficient - K is the partition coefficient of drug between the membrane and drug core - ℓ is the diffusional path length (thickness of coat in the ideal case) - C is the concentration difference across the membrane.

    Diffusion CR Formulations: Reservoir Devices Preparation

    • Drug containing cores in tablets
    • Compression coating of drug cores
    • Air suspension coating of drug pellets
    • Drug particles: Microencapsulation of drug particles to be incorporated into tablets or capsules

    Diffusion CR Formulations: Reservoir Devices Release Rate

    • Several factors affect the release rate.
      • Partition of drug between membrane and core
      • Thickness of the coating
      • Polymer ratio in the coating
      • Hardness of microcapsules

    Ion Exchange Resins

    • Quaternary ammonium anion exchange resin
    • Used in reducing blood cholesterol level

    Osmotic Controlled Delivery Systems

    • Osmotic pressure is the driving force that generates constant drug release.
    • These systems are not affected by physiological factors such as type of food intake, gastric pH, and patient-to-patient variability.
    • The delivery strategy and release profile can be customized to suit various APIs with a wide range of thermodynamic properties.
    • Due to this uniqueness, osmotic systems have witnessed increasing interest and the number of marketed products has doubled in the past decades.

    Osmotic Controlled Delivery Systems: Basic Principles

    • When exposed to water or body fluid, water will flow into the core due to an osmotic pressure difference across the coating membrane.

    • Under this osmotic pressure gradient, the volume flow of water into the core reservoir, dV/dt, is expressed as:

      dV/dt = (Ak/h) ( - P)
      

      where: - A, k and h are the area, membrane permeability, and thickness, respectively -  is the osmotic pressure difference - P is the hydrostatic pressure difference.

      • If the orifice is sufficiently large, the hydrostatic pressure difference will be small compared to the osmotic pressure difference, and the equation becomes:
      dV/dt = (Ak/h) 
      
      • Drug is pumped out of the system through the orifice at a controlled rate, dM/dt which is equal to the volume flow rate of water into the core multiplied by the drug concentration, Cs.

    Methylphenidate HCL Triple layer Osmotic Pump: Concerta®

    • Osmotically active trilayer core surrounded by a semipermeable membrane with an immediate-release drug overcoat.
    • The trilayer core is composed of two drug layers containing the drug and excipients, and a push layer containing osmotically active components.
    • There is a precision-laser drilled orifice on the drug-layer end of the tablet.
    • In an aqueous environment, the drug overcoat dissolves within one hour, providing an initial dose of methylphenidate.
    • Water permeates through the membrane into the tablet core.
    • As the osmotically active polymer excipients expand, methylphenidate is released through the orifice.

    Gastroretentive Systems

    • The maximum achievable sustained drug release is subject to inter-individual variations with an average gastrointestinal (GI) transit time of around 24 h in humans.
    • Retention of oral dosage forms in the upper GIT causes prolonged contact time of drug with the GI mucosa, leading to higher bioavailability, therapeutic efficacy, reduced time intervals for drug administration, potentially reduced dose size, and thus improved patient compliance.

    Gastroretentive Systems: Selection of APIs

    • Gastroretentive DDSs exhibiting controlled drug release are significantly important for drugs that are:
      • Acting locally in the stomach (e.g., antibiotics against Helicobacter Pylori, antacids and misoprostol)
      • Absorbed incompletely due to a relatively narrow window of absorption in the GIT
      • Unstable in the intestinal or colonic environment
      • Exhibit low solubility at high pH values

    Gastroretentive DDS, are not suitable for drugs that:

    - May cause gastric lesions
    - Are unstable in the strong acidic pH of the stomach
    - Are absorbed throughout the gastrointestinal tract
    

    Gastroretentive Systems: Types

    • The most common approaches used to increase the gastric residence time of pharmaceutical dosage forms include:
      • Co-administration of the DDS with pharmacological agents that slow gastric motility
      • Bioadhesive systems
      • Size increasing systems
      • Density controlled systems

    Gastroretentive Systems: Size increasing systems

    • To facilitate swallowing, the dosage form should have an initially small size.
    • Once in the stomach, the dosage forms should quickly increase in size to prevent premature emptying through the pylorus.
    • To avoid accumulation following multiple administrations, the system should be cleared from the stomach after a predetermined time interval.
    • The dosage form should have no effect on gastric motility or emptying process.
    • The increase in the systems’ size can be based on several principles including expansion due to swellable excipients or unfolding and/ or shape modification (to complex geometric shapes) in the stomach.

    Gastroretentive Systems: Effervescent Floating

    • The inner layer of effervescent agents containing sodium bicarbonate and tartaric acid is divided into 2 sublayers to avoid direct contact between the 2 agents.
    • These sublayers are surrounded by a swellable polymer membrane containing polyvinyl acetate and purified shellac.
    • When this system is immersed in the buffer at 37ºC, it settles down and the solution permeates into the effervescent layer through the outer swellable membrane.

    Enteric Polymers

    • Enteric polymers are insoluble at a pH of 6 or below (stomach) but become soluble at a pH above 6 (intestine).
    • The functional group ionizes at higher pH, allowing it to solubilize the polymer.
    • Enteric coated tablets are coated with these polymers, preventing the drug from being released in the stomach.
    • Common enteric polymers include Cellulose acetate phthalate, Hydroxypropyl methyl cellulose phthalate, Hydroxypropyl methyl cellulose acetate-succinate, Polyvinyl acetate phthalate, and Methacrylic acid copolymers.

    Controlled Release Dosage Forms

    • The US Pharmacopoeia defines modified release dosage forms as those that release drugs at a controlled rate and location to achieve therapeutic objectives not offered by conventional dosage forms.
    • Controlled release, prolonged release, sustained or slow release, and long-acting are synonymous terms for extended release.

    Controlled Release Drug Delivery

    • Focuses on delivering the drug at a predetermined rate over a defined period.
    • It aims to achieve a constant drug release irrespective of the drug concentration, ideally with a zero-order release.

    Sustained Release Dosage Forms

    • Characterized by an initial immediate release (loading dose) to rapidly achieve therapeutic efficacy.
    • Subsequent slow release (maintenance dose) maintains therapeutic levels for prolonged durations.
    • It may or may not be controlled release, implying slow release but not necessarily constant.

    Controlled Release Vs Immediate Release

    • Consider MEC (Minimum Effective Concentration), MTC (Minimum Toxic Concentration), the therapeutic window, and drug half-life.

    Reasons for Controlled Release

    • To achieve sustained therapeutic effect.
    • To reduce dosing frequency.
    • To minimize side effects.
    • To improve patient compliance.
    • To target specific sites of action.

    Drug Release Mechanisms

    • Microencapsulated Particles/Coated Granules: The drug is compressed with a slowly dissolving carrier.
    • Coating: Individual drug particles or granules are coated with a slow-dissolving material. This is done by varying the coating thickness and composition to control drug release rates.
    • Matrix Systems: The drug is compressed into a tablet with a slowly dissolving matrix. This matrix controls the drug dissolution rate by regulating the rate at which the dissolution fluid penetrates the matrix.
    • Osmotic Systems: Drug release rate is directly proportional to the osmotic pressure of the core formulation.
      • SCOT (Single-Composition Osmotic Tablet): A single-layer osmotic pump with a porous membrane that accommodates a high drug load.
      • SEOP (Self-Emulsifying Elementary Osmotic Pump): An osmotic pump that self-emulsifies in the gastrointestinal tract.

    Advantages of Osmotic Controlled Delivery Systems

    • Zero-order release
    • Capability for pulsed or delayed release.
    • Independent of gastric pH and physiological conditions.
    • Release mechanism is independent of drug properties.
    • High correlation between in vitro and in vivo performance.

    Gastroretentive Systems

    • Gastric retention systems increase the residence time of the drug in the stomach, enhancing drug absorption.
    • Common approaches to achieve gastric retention include:
      • Co-administration of pharmacological agents
      • Bioadhesive systems
      • Size increasing systems
      • Density controlled systems
    • Effervescent floating systems utilize effervescent agents and swellable polymer membranes to float in the stomach.
      • Effervescent floating Systems: utilizes effervescent agents and swellable polymer membranes to float in the stomach.
      • The outer layer of swellable polymer membrane surrounding the effervescent agents controls the release of gas, allowing the tablet to float in the stomach.
      • The effervescent agent releases gas, causing the tablet to float.

    Example Controlled Release Products

    • Procardia XL (Nifedipine): An antihypertensive drug with a half-life of 2 hours. It is practically insoluble in water. Procardia XL utilizes a PPOS (Polymeric Osmotic Pump System) to control the release of Nifedipine.
    • Tegretol® XR (Carbamazepine): An anticonvulsant drug with a half-life of 30 hours. It is poorly soluble in water. Tegretol® XR uses a SEOP (Self-Emulsifying Osmotic Pump) to control the release of Carbamazepine.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz delves into the fundamental concepts of bioavailability and the Biopharmaceutical Classification System (BCS) of drugs. It covers the principles of drug absorption, various administration routes, and the classification of drugs based on solubility and permeability. Test your understanding of these critical pharmacological concepts.

    More Like This

    Bioavailability and Nutrition
    4 questions
    Bioavailability Studies Quiz
    5 questions
    Bioavailability Studies Quiz
    5 questions
    Bioavailability and Bioequivalence Quiz
    9 questions
    Use Quizgecko on...
    Browser
    Browser